DNAnexus named to the 2026 Inc. 5000 list, the most prestigious ranking of America's fastest-growing private companies. August 11, 2026 san francisco biotechnology network news news, syndication comments off on dnanexus named to the 2026 Inc. 5000 list, the most prestigious ranking of America's fastest-growing private companies. MOUNTAIN VIEW, Calif.-(BUSINESS WIRE)- #AI-DNAnexus today announced it has been named to the 2026 Inc. 5000 list, the annual list of the fastest-growing private companies in America. Click here to view original post

DNAnexus scales ai-driven capabilities: 17-year multiomics pioneer powers next Era of precision health. Today, DNAnexus signals a bold new chapter in AI-powered precision health with several new product innovations and solution packages that extend its position as the purpose-built platform where the world's most scientifically complex data becomes the world's most powerful AI fuel. These innovations solidify DNAnexus's dual role: an AI-Enabled platform that accelerates discovery for all scientists via native intelligence, and an AI-Enabling platform providing the governed, omics-native infrastructure for building and running the next generation of AI models and autonomous agents. "DNAnexus is evolving from the leading data infrastructure provider for precision health into the intelligent orchestration layer for modern, AI-driven science," said Thomas Laur, CEO of DNAnexus. "Omics data is not like other health data - its scale, biological complexity, and regulatory demands are exactly why general-purpose platforms fall short, and where we have spent 17 years building our advantage. Our latest innovations ensure that multimodal omics data is no longer a siloed challenge to manage, but a high-velocity, AI-ready enterprise asset that powers scientific discovery at industrial scale." Built for the Omics AI Era As research generates unprecedented volumes of genomic, multiomic, imaging, and clinical data, organizations face growing challenges not only in managing this scale, but in converting it into a reusable, Tier 1 enterprise asset. Omics data accumulates at a velocity that exceeds every other category of digital information - and a single whole genome alone represents gigabytes of biologically irreducible complexity. DNAnexus was built for these unique demands, closing the gap between biology and discovery through its expanded offerings. They include: * AI-Assisted Exploration and Productivity (Omics Data Agent). A GenAI-powered conversational interface that transforms how you interact with complex datasets, enabling no-code cohort creation, instant data summarization, and sophisticated longitudinal queries - all through simple, natural language. * Democratized Discovery: Break down technical barriers with a self-serve interface that makes deep omics analysis accessible to every researcher, regardless of coding expertise. * Cross-Modal Synergy: Effortlessly bridge the gap between disparate datasets for a unified view of your research. * Accelerated Impact: Dramatically reduce time-to-insight by eliminating the engineering bottleneck, allowing your team to focus on science, not syntax. * Enhanced Multiomic Ingestion, Representation, and Cohorting: Users can now ingest a wide variety of germline DNA-Seq, somatic DNA-Seq, and tissue RNA-Seq expression data. All data is annotated and contextualized with relevant ontologies to make them readily available for cohorting and for AI use cases. The DNAnexus Cohort Browser has been expanded with new intuitive visualizations for these supported modalities, including variant frequency matrices, protein lollipop plots, and gene expression violin-style plots. * Rapid Model Development for Serious Science (AutoML Assistant). A conversational copilot that enables teams to go from idea to model up to 80% faster, prototyping, refining, and making machine learning a reality without weeks of costly custom development. * A Foundation for AI-Ready Data (Omics Data Catalog). A centralized hub embedded within the secure DNAnexus platform for governed metadata management that makes multimodal scientific data discoverable, comparable, and reusable - transforming single-use datasets into reusable enterprise assets and the trusted fuel for AI models and agents. Building on these innovations are new solutions packages that are purpose-built to address the specific operational and scientific challenges of different organizations across life sciences, including Diagnostic Labs, Biopharma R&D, Health Systems and Academic Medical Centers. Additionally, DNAnexus's Analysis Accelerators provide ready-to-run starting points for common computational biology tasks in drug discovery across all Life Sciences verticals, including Single Cell Analysis, Molecular Modeling and Target Validation. AI-Driven Now. AI-Defining Next. For 17 years, DNAnexus has anchored regulated pharma, biobanks, and clinical providers with unmatched governance and omics-native depth. Today, this foundation provides the essential framework for scientifically valid AI. By bridging the gap between raw multimodal data and clinical discovery, DNAnexus enables health leaders to operationalize AI across critical workflows with full regulatory readiness. This seamless integration of intelligence and compliant infrastructure ensures the journey from data to breakthrough is not just scalable, but reproducible for scientists and clinicians worldwide. To learn more about the innovations and solution packages, visit: https://www.dnanexus.com/innovation-hub. About DNAnexus Founded in 2009, DNAnexus is the enterprise orchestration platform for precision health. A pioneer in cloud-based omics and purpose-built bioinformatics for life sciences, DNAnexus helps customers contextualize, orchestrate, and federate multiomic and real-world data to derive actionable insights and accelerate the journey from sequence to scientific breakthrough. DNAnexus accomplishes this through its compliance-first, AI-enabled platform, equipped to handle extreme scale and complex data processing for genomics, multiomics, and beyond. Get started at: www.dnanexus.com.